Läkemedel denosumab
- Published
- 5 February 2026
- Estimated value
- 71,907,000 kr
- Place of performance
- SE224
- Procedure
- open
- Lots
- 2
- Notice number
- 00084970-2026
- Reference
- 7be9bd2c-118d-44f5-9471-0ed9b4be7aa6
- Official source
- Official source
CPV codes
- 33600000Productos farmacéuticos
- 33652000Agentes antineoplásicos e inmunomoduladores
Description
Upphandlingen avser rekvirerade läkemedel, substans denosumab, för succesiva leveranser till Region Skåne och de privata vårdgivare som har avtal med Region Skåne.
Awards
| Awarded to | Amount | Date |
|---|---|---|
| Sandoz A/S | — | — |
| Øresund Pharma ApS | — | — |
| Amgen Aktiebolag | — | — |
| Celltrion Sweden AB | — | — |
| Gedeon Richter Nordics AB | — | — |
| Fresenius Kabi AB | — | — |
| Zentiva Denmark ApS | — | — |
| Medical Valley Invest AB | — | — |
| Samsung Bioepis NL B.V. | — | — |
| Accord Healthcare AB | — | — |
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is 71,907,000 kr.
- Who is the buyer of this tender?
- The contracting authority is Region Skåne, Koncernstab inköp och ekonomistyrning (European Union).
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.